Actinomycin D for injection (Tiziana Life Sciences)

N/A

Report date: 2026/01/23 17:10:01

Base Information

Drug NameActinomycin D for injection (Tiziana Life Sciences)
Drug Alias NameActinomycin DAct DNanoparticle-based Act DNanoparticle-based formulation of Actinomycin DNP-ACT D +[6] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Leukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRasna Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTiziana Life Sciences LtdRasna Therapeutics IncTiziana Life Sciences Plc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Leukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A